Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.
-
Upload
vivian-gregory -
Category
Documents
-
view
220 -
download
1
Transcript of Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.
![Page 1: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/1.jpg)
Pancreatic Hormones and Insulin Receptor Agonists
Hongmei Li
Mar. 21th, 2006
![Page 2: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/2.jpg)
The bulk of the pancreas is an exocrine gland secreting pancreatic fluid into the duodenum after a meal.
Inside the pancreas are millions of clusters of cells called islets of Langerhans. The islets are endocrine tissue containing four types of cells. In order of abundance, they are:
beta cells, which secrete insulin and amylin; alpha cells, which secrete glucagon; delta cells, which secrete somatostatingamma cells, which secrete a polypeptide.
![Page 3: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/3.jpg)
Pancreatic Hormones
Insulin Amylin Glucagon Somatostatin Pancreatic Polypeptide
![Page 4: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/4.jpg)
A chain
B chain
Beta cells have channels in their plasma membrane that serve as glucose detectors. Beta cells secrete insulin in response to a rising level of circulatingglucose.
Insulin is a small protein consisting of an A chain of 21 amino acids linked by two disulfide (S—S) bridges to a B chain of 30 amino acids.
![Page 5: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/5.jpg)
Insulin affects many organs:
It stimulates skeletal muscle fibers.
It stimulates liver cells.
It acts on fat cells
It inhibits production of certain enzyme.
In each case, insulin triggers these effects by binding to the insulin receptor.
glucoseuptake
glycogen synthesis
protein synthesis
amino acids uptake
enzymeproduction
glycogenbreaking
fat synthesis
![Page 6: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/6.jpg)
Pancreatic Hormones
Insulin Amylin Glucagon Somatostatin Pancreatic Polypeptide
![Page 7: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/7.jpg)
β Amylin
Amylin is a peptide of 37 amino acids.
It inhibits the secretion of glucagon; It slows the emptying of the stomach; It sends a satiety signal to the brain.
All of its actions tend to supplement thoseof insulin, reducing the level of glucose inthe blood.
![Page 8: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/8.jpg)
Pancreatic Hormones
Insulin Amylin Glucagon Somatostatin Pancreatic Polypeptide
![Page 9: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/9.jpg)
αGlucagon
Glucagon, a polypeptide of 29 amino acids, acts principally on the liver.
It stimulates the conversion of glycogen into glucose. It stimulates the conversion of fat and protein into intermediate metabolites that are ultimately converted into glucose.
Glucagon secretion is stimulated by low levels of glucose in the blood; inhibited by high levels, and inhibited by amylin.
![Page 10: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/10.jpg)
Pancreatic Hormones
Insulin Amylin Glucagon Somatostatin Pancreatic Polypeptide
![Page 11: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/11.jpg)
δ Somatostatin
Somatostatin consists of two polypeptides,
one of 14 amino acids and the other of 28.
They work together to reduce the rate at
which food is absorbed in the intestine.
![Page 12: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/12.jpg)
Pancreatic Hormones
Insulin Amylin Glucagon Somatostatin Pancreatic Polypeptide
![Page 13: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/13.jpg)
γPancreatic Polypeptide by Gamma Cells
The gamma cells of the islets secrete a 36-amino-acid pancreatic polypeptide, which reduces appetite.
![Page 14: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/14.jpg)
The insulin receptor (IR) is a transmembrane glycoprotein, composed of 2α and 2β domains.
. Its intracellular tyrosine
kinase domain is activated by binding of insulin, leading to a cascade of signaling events.
![Page 15: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/15.jpg)
Who need insulin medicine
Type I (insulin dependent) diabetes patients whose body produces no insulin.
Type 2 diabetes patients that do not always produce enough insulin.
Treatment
subcutaneous injection
![Page 16: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/16.jpg)
Stage 1 Insulin was extracted from the glands of cows and pigs. (1920s)
Stage 2 Convert pig insulin into human insulin by removing the one amino acid that distinguishes them and replacing it with the human version.
Insulin drug evolution
![Page 17: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/17.jpg)
Stage 3 Insert the human insulin gene into E. coli and culture the recombinant E.coli to produce insulin (trade name = Humulin®). Yeast is also used to produce insulin (trade name =
Novolin®) (1987).
Recombinant DNA technology has also made it possible to manufacture slightly-modified forms of human insulin that work faster (Humalog® and NovoLog®) or slower (Lantus®) than regular human insulin.
![Page 18: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/18.jpg)
Types of insulin
• Regular insulins
• Insulin analogs
• Pre-mixed insulin
Short peptide mimics
![Page 19: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/19.jpg)
Regular insulins:
Human insulin: Humulin® (from E.coli),
Novalin® (from yeast) NPH - neutral protamine Hagedorn (NPH),
protamine mixed. Lente® insulin / Ultralente® insullin-
zinc added
![Page 20: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/20.jpg)
Types of insulin
• Regular insulins
• Insulin analogs
• Pre-mixed insulin
Short peptide mimics
![Page 21: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/21.jpg)
Insulin Analogs:
Fatty Acid Acylated insulins
Insulin Lispro (Humalog®) (1996)
Insulin Aspart (NovoLog®) (2000)
Insulin Glargine (Lantus®) (2002)
Insulin Detemir (Levemir®) (Jun.,2005)
Insulin Glulisine (Apidra®) (Jan., 2006)
![Page 22: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/22.jpg)
Amino Acid Substitutons
A- chainPosition
B- chain Position
Source/Type
A21 B3 B28 B29 B30 B31 AndB32
Human Asn Asn Pro Lys Thr
Aspart Asn Asparticacid
Lys Thr
Lispro Asn Lys Pro Thr
Glulisine Asn Lys Pro Glu Thr
Glargine Gly Pro Lys Thr Arg
Detemir Lys Myristicacid
rapid-acting
long-acting
![Page 23: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/23.jpg)
![Page 24: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/24.jpg)
Types of insulin
• Regular insulins
• Insulin analogs
• Pre-mixed insulin
Short peptide mimics
![Page 25: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/25.jpg)
Types of insulin
• Regular insulins
• Insulin analogs
• Pre-mixed insulin
Short peptide mimics
![Page 26: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/26.jpg)
Insulin receptors were used as targets to screen surrogate peptides in random peptide phage display libraries.
Short surrogate peptides
IR
![Page 27: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/27.jpg)
Short surrogate peptides
H2C-D117: 14 a.a. RP9-S371: 16 a.a. 20E2-D118: 24 a.a.
![Page 28: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/28.jpg)
Future Directions for new IR agonists
Increased Stability Less Variability High Selective Action Ultra Rapid Onset Ultra Long Activity W/O side effects
![Page 29: Pancreatic Hormones and Insulin Receptor Agonists Hongmei Li Mar. 21th, 2006.](https://reader034.fdocuments.net/reader034/viewer/2022051416/56649f215503460f94c399a2/html5/thumbnails/29.jpg)
References
Renuka C. P. et.al (2002) J. Biol. Chem. 277, 22590–4 Zoltan V. AND William C. D. (2001) Pharm. Rev. 52, 1-9 Lauge S. et. Al (2003) PNAS 100, 4435-9 Mark R. B. (1997) J. of Clin. Endoc.& Met. 82, 3-7 Gianni C. (1992) FEBS 307, 66-70 Irl B. H., (2001) Clin. Diabetes 19, 146-7 BRUCE W. B. and POUL S. (2001) Diabetes care 24,69-72 http://www.indstate.edu/thcme/mwking/diabetes.html